Dr Maor Sauler, MD | |
785 Howard Ave, New Haven, CT 06519-1612 | |
(203) 785-4198 | |
Not Available |
Full Name | Dr Maor Sauler |
---|---|
Gender | Male |
Speciality | Pulmonary Disease |
Experience | 18 Years |
Location | 785 Howard Ave, New Haven, Connecticut |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013191949 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0200X | Internal Medicine - Critical Care Medicine | 004770 (Connecticut) | Secondary |
207RP1001X | Internal Medicine - Pulmonary Disease | 004770 (Connecticut) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Yale-new Haven Hospital | New haven, CT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Yale University | 9436061736 | 2241 |
News Archive
A Heart and Stroke Foundation researcher has discovered what could be the first truly effective breakthrough in the diagnosis and treatment of pulmonary hypertension, a devastating, life-threatening condition which results in an enlargement of the heart.
Eckert & Ziegler Radiopharma GmbH has received a recommendation from the European Medicines Agency for approval of its pharmaceutical 68Ge/68Ga generators.
Tanira B.D. Ferreira, M.D., FCCP, chief medical officer of University of Miami Hospital and Clinics, was one of three authors featured in the New England Journal of Medicine for her expertise in how to manage elective surgeries during COVID-19 surges.
Type 2 diabetes is a major risk factor of cardiovascular diseases, such as coronary artery disease and heart failure, as well as premature death. To prevent or at least delay complications, regular health care visits and good control of blood glucose, low-density lipoprotein cholesterol (LDL-C) and other risk factors are needed.
› Verified 2 days ago
Entity Name | Yale University |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015 |
News Archive
A Heart and Stroke Foundation researcher has discovered what could be the first truly effective breakthrough in the diagnosis and treatment of pulmonary hypertension, a devastating, life-threatening condition which results in an enlargement of the heart.
Eckert & Ziegler Radiopharma GmbH has received a recommendation from the European Medicines Agency for approval of its pharmaceutical 68Ge/68Ga generators.
Tanira B.D. Ferreira, M.D., FCCP, chief medical officer of University of Miami Hospital and Clinics, was one of three authors featured in the New England Journal of Medicine for her expertise in how to manage elective surgeries during COVID-19 surges.
Type 2 diabetes is a major risk factor of cardiovascular diseases, such as coronary artery disease and heart failure, as well as premature death. To prevent or at least delay complications, regular health care visits and good control of blood glucose, low-density lipoprotein cholesterol (LDL-C) and other risk factors are needed.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Maor Sauler, MD 300 Cedar St # 441-s, Po Box 208057, New Haven, CT 06519-1612 Ph: () - | Dr Maor Sauler, MD 785 Howard Ave, New Haven, CT 06519-1612 Ph: (203) 785-4198 |
News Archive
A Heart and Stroke Foundation researcher has discovered what could be the first truly effective breakthrough in the diagnosis and treatment of pulmonary hypertension, a devastating, life-threatening condition which results in an enlargement of the heart.
Eckert & Ziegler Radiopharma GmbH has received a recommendation from the European Medicines Agency for approval of its pharmaceutical 68Ge/68Ga generators.
Tanira B.D. Ferreira, M.D., FCCP, chief medical officer of University of Miami Hospital and Clinics, was one of three authors featured in the New England Journal of Medicine for her expertise in how to manage elective surgeries during COVID-19 surges.
Type 2 diabetes is a major risk factor of cardiovascular diseases, such as coronary artery disease and heart failure, as well as premature death. To prevent or at least delay complications, regular health care visits and good control of blood glucose, low-density lipoprotein cholesterol (LDL-C) and other risk factors are needed.
› Verified 2 days ago
Dr. Brian Christopher Cambi, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 333 Cedar St, Dcb 3, New Haven, CT 06510 Phone: 203-785-4129 Fax: 203-737-2437 | |
Ms. Maryam Gondal, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 330 Cedar Street, Bb 114, New Haven, CT 06510 Phone: 203-785-4184 | |
Matthew Joseph Mcconnell, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 333 Cedar St, Ynhh Internal Medicine-gi,section Of Digestive Diseases, New Haven, CT 06510 Phone: 203-785-7012 | |
Marie Anjeliese Rodriguez, Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 | |
Dr. Margaret M Xu, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 20 York St, New Haven, CT 06510 Phone: 203-688-4242 | |
Carola Marte, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1450 Chapel St, Haelen Center, New Haven, CT 06511 Phone: 203-789-4135 Fax: 203-867-5241 | |
Jeanette M Tetrault, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Long Wharf Dr, New Haven, CT 06511 Phone: 203-781-4600 Fax: 203-781-4624 |